Amedisys Inc (AMED) EPS Estimated At $0.53

October 7, 2017 - By Winifred Garcia

 Amedisys Inc (AMED) EPS Estimated At $0.53
Investors sentiment increased to 1.75 in 2017 Q2. Its up 0.69, from 1.06 in 2017Q1. It improved, as 9 investors sold Amedisys Inc shares while 42 reduced holdings. 32 funds opened positions while 57 raised stakes. 30.18 million shares or 2.20% less from 30.86 million shares in 2017Q1 were reported.
Amalgamated Natl Bank holds 0.01% or 3,920 shares in its portfolio. Parkside Natl Bank Trust has 0% invested in Amedisys Inc (NASDAQ:AMED). Moreover, New York State Common Retirement Fund has 0% invested in Amedisys Inc (NASDAQ:AMED). The Minnesota-based First Light Asset Management Ltd Llc has invested 1.95% in Amedisys Inc (NASDAQ:AMED). Metropolitan Life Insur New York has invested 0.01% of its portfolio in Amedisys Inc (NASDAQ:AMED). Eaton Vance Mngmt accumulated 182,707 shares. Savings Bank Of Montreal Can invested in 0% or 19,575 shares. Amer Intl Gru Inc reported 0% stake. Teachers Retirement System Of The State Of Kentucky holds 0.01% or 11,167 shares. 4.84M were reported by Kohlberg Kravis Roberts And Lp. Riverhead Cap Mgmt stated it has 0.01% in Amedisys Inc (NASDAQ:AMED). Gilder Gagnon Howe & Com Ltd holds 819,433 shares. Pillar Pacific Mgmt Lc invested in 0.07% or 7,600 shares. Northwestern Mutual Wealth Communications reported 34 shares or 0% of all its holdings. Millrace Asset Grp Incorporated has 25,900 shares.

Since May 8, 2017, it had 1 insider purchase, and 4 insider sales for $4.35 million activity. On Monday, May 8 Ginn Scott G sold $1.40 million worth of Amedisys Inc (NASDAQ:AMED) or 23,828 shares. 35,496 shares were sold by Pernosky Lawrence R, worth $2.09 million on Monday, May 8. NETTERVILLE JAKE L sold $600,000 worth of stock. The insider Hall Linda J. sold 5,000 shares worth $300,800.

Investors wait Amedisys Inc (NASDAQ:AMED) to report on November, 2. its quarterly earnings Wall Street analysts expect $0.53 EPS, up $0.17 or 47.22 % from last year’s $0.36 same quarter earnings. This translates into $17.68M profit for AMED giving the stock a 24.88 P/E. This is assuming the current $0.53 EPS is accurate. Amedisys Inc’s Wall Street analysts see -14.52 % negative EPS growth, taking into account the $0.62 EPS reproted in the previous quarter, The stock decreased 1.35% or $0.72 on October 6, reaching $52.75. About 197,681 shares traded. Amedisys Inc (NASDAQ:AMED) has risen 15.02% since October 8, 2016 and is uptrending. It has underperformed by 1.68% the S&P500.

Amedisys Inc (NASDAQ:AMED) Ratings Coverage

Among 13 analysts covering Amedisys Inc. (NASDAQ:AMED), 4 have Buy rating, 0 Sell and 9 Hold. Therefore 31% are positive. Amedisys Inc. had 26 analyst reports since September 1, 2015 according to SRatingsIntel. The stock of Amedisys Inc (NASDAQ:AMED) has “Equal-Weight” rating given on Friday, June 17 by Stephens. The company was maintained on Friday, May 6 by RBC Capital Markets. The firm earned “Hold” rating on Monday, August 14 by RBC Capital Markets. The stock of Amedisys Inc (NASDAQ:AMED) earned “Buy” rating by Mizuho on Tuesday, January 19. The firm earned “Buy” rating on Wednesday, June 7 by Jefferies. The firm earned “Outperform” rating on Monday, February 8 by Oppenheimer. Mizuho upgraded the stock to “Buy” rating in Monday, November 7 report. The rating was maintained by Robert W. Baird on Wednesday, January 13 with “Neutral”. Oppenheimer maintained it with “Outperform” rating and $45 target in Thursday, March 10 report. RBC Capital Markets maintained it with “Hold” rating and $5600 target in Monday, July 10 report.

Amedisys, Inc. is a healthcare services company. The company has market cap of $1.76 billion. The Company’s divisions are Home Health, Hospice, Personal Care and Other. It has a 44.88 P/E ratio. The Firm is a well-known provider of home health, hospice and personal care services.

More notable recent Amedisys Inc (NASDAQ:AMED) news were published by: Globenewswire.com which released: “Amedisys Closes on Acquisition of Intercity Home Care” on October 02, 2017, also Prnewswire.com with their article: “Bernstein Litowitz Berger & Grossmann LLP and Wolf Popper LLP Announce a …” published on September 27, 2017, Globenewswire.com published: “Scott Ginn Promoted to Chief Financial Officer at Amedisys” on October 06, 2017. More interesting news about Amedisys Inc (NASDAQ:AMED) were released by: Globenewswire.com and their article: “Seventy-One Amedisys Care Centers Receive SHPBest Awards” published on September 21, 2017 as well as Nasdaq.com‘s news article titled: “Amedisys’ Arm Buys Intercity Home Care, Boosts US Base” with publication date: October 03, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com